Lausanne, Vaud, SwitzerlandFull time
OverviewApplicationShare this jobSVGs not supported by this browser.
SVGs not supported by this browser.
FacebookSVGs not supported by this browser.
TwitterSVGs not supported by this browser.
LinkedInDebiopharm Group™ is a Swiss-headquartered global biopharmaceutical group active in the life science areas of drug development, GMP manufacturing of proprietary drugs, diagnostic tools and investment management. Debiopharm International SA is focused on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide.
For our Clinical Operations Department based at our Headquater in Lausanne, we are looking for a
Associate Director / Lead Global Clinical Trial Management - Phase III (100%)
The Associate Director / Lead Clinical Trial Management (CTM) Ph III trials is responsible and accountable for leading, planning, implementing and delivering large international Phase III clinical trials in Oncology and onco-haematology, to ensure that studies are carried out according to the protocol, SOPs, applicable regulations and principles of Good Clinical Practice.
Associate Director / Lead Clinical Trial Management leads planning and management of the assigned clinical study from an end-to-end trial management perspective to achieve Global Program Team objectives. Acts as Study Team Lead representative at Core Team level. Enables an empowered organization, which can navigate in a matrix environment and adjust quickly to business needs. Point of escalation for resolution of trial management operational issues within assigned program.
Your responsibilities will be but not limited to: